Latest News about Partner Content
Recent news which mentions Partner Content
What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?
August 23, 2023
From Benzinga
Dental Savings Plans Give The 76% Of Seniors Without Dental Insurance A Way To Manage The Costs Of Oral Care
August 23, 2023
From Benzinga
All About Gold IRAs – What Makes Them Attractive During Times Of Economic Turmoil, And Why You May Want To Invest
August 23, 2023
From Benzinga
From Benzinga
Flow Beverage Corp Could Get A Boost In Path To Profitability As Nonalcoholic Beverage Market Heads For A Summer Rally
August 22, 2023
From Benzinga
New Industries For Electrification: HEVI's Portfolio Of Electric Vehicles Could See Applications In A Range Of Underelectrified Industries
August 22, 2023
From Benzinga
From Benzinga
From Benzinga
Petro-Victory: Fueling Brazil's Onshore Oil And Gas Potential
August 21, 2023
From Benzinga
Imagine Joining All Cryptocurrency Networks Into A Super-Network That Is Cross-Chain And Protocol-Driven — Swopblock Is Doing Just That
August 21, 2023
From Benzinga
From Benzinga
From Benzinga
Shapeways Transforms Multi-Billion-Dollar Manufacturing Industry; Its Proprietary Software Empowers On-Demand Production
August 21, 2023
Tickers
SHPW
From Benzinga
ESE Entertainment Enters Strategic Partnership With BlackPines, To Sell 70% Stake In GameAddik To BlackPines For About $9 Million
August 21, 2023
Tickers
ENTEF
From Benzinga
From Benzinga
Nearly 2 In 5 American Workers Are Now Freelance – Here's How They're Keeping Dental Costs Down Even Without Employer-Sponsored Dental Insurance
August 17, 2023
From Benzinga
From Benzinga
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
August 17, 2023
Tickers
HLTH
From Benzinga
From Benzinga
Investing In The Emerging Hydrogen Economy Now
August 16, 2023
From Benzinga
Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
August 16, 2023
Tickers
AGRX
From Benzinga
Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
August 15, 2023
Tickers
WINT
From Benzinga
From Benzinga
This Company At The Intersection Of Two Multi-Billion Dollar Industries Offers A Solution To America's Biggest Mobile Source Of Air Pollutants
August 15, 2023
From Benzinga
How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators
August 15, 2023
Tickers
WINT
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.